A Phase 1 Study to Evaluate the Pharmacokinetic Interaction Potential Between BIIB074 and an Oral Contraceptive Regimen in Healthy Female Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Mar 2019
Price : $35 *
At a glance
- Drugs Vixotrigine (Primary) ; Estradiol/levonorgestrel
- Indications Erythromelalgia; Neuropathic pain; Trigeminal neuralgia
- Focus Pharmacokinetics
- Sponsors Biogen
- 16 Mar 2019 Results evaluating pharmacokinetics of vixotrigine and oral contraceptives presented at the 120th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 24 Sep 2018 Status changed from recruiting to completed.
- 31 Aug 2018 Biomarkers information updated